RIBONUCLEIC ACID (RNA) MARKERS MARKET ANALYSIS

Regional Analysis

Global Ribonucleic Acid (RNA) Markers Market- Regional Analysis

Among all regions, North America region is expected to dominate the market over the forecast period. This is attributed due to the North America hold 34.6% market share owing to increasing research and development activities by the market players in the North America region. For instance, in the year 2021, Pfizer Inc., a pharmaceutical and Biotechnology company invested a total of US$ 120 million in four clinical-stage biotech companies, as part of the Pfizer Breakthrough Growth Initiative (PBGI), during the second half of the year 2020. Through PBGI, Pfizer Inc., invested up to US$ 500 million in biotechnology companies, which will provide funding and further access to Pfizer’s scientific expertise, which in turn, will help in the completion of the clinical development programs. Such investments are expected to increase the use of RNA markers and help in the growth of the market over the forecast period.